SCHEMBL20150363

SCHEMBL20150363

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4C(F)(F)F)ccc2n3-c2cc(C#N)ccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.35
TRPA1 O75762 1/20 0.34
S1PR1 P21453 4/20 0.33
S1PR3 Q99500 3/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
HSD11B1 P28845 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114552 0.92 ABCG2 (0.36) ABCG2MEN1ALDH1A1LMNACYP1A2
SCHEMBL20114558 0.89 PTGER4 (0.38) ABCG2MEN1ALDH1A1LMNACYP1A2
SCHEMBL20150362 0.89 S1PR1 (0.34) ARS1PR1S1PR3ABCG2HCRTR1
SCHEMBL22243178 0.88 CYP1A2 (0.37) ABCG2MEN1ALDH1A1LMNACYP1A2
SCHEMBL20156112 0.87 S1PR1 (0.34) ARTRPA1S1PR1S1PR3ABCG2
SCHEMBL22243189 0.86 CYP1A2 (0.36) ABCG2MEN1ALDH1A1LMNACYP1A2
SCHEMBL22985684 0.86 S1PR1 (0.36) ARTRPA1S1PR1S1PR3ABCG2
SCHEMBL21090882 0.86 ABCG2 (0.35) ABCG2MEN1ALDH1A1LMNACYP1A2
SCHEMBL22268466 0.86 KDM4E (0.39) ABCG2MEN1ALDH1A1LMNAKMT2A
SCHEMBL20156106 0.86 ABCG2 (0.35) ABCG2MEN1ALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 AR 3892/4885TRPA1 299/4885S1PR1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.